Results 111 to 120 of about 33,200 (128)

GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer

Biochimica Et Biophysica Acta - Molecular Cell Research, 2020
Jintao Lin, Weifeng Mao
exaly  

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment

Cells, 2020
James Mccubrey, Giuseppe Montalto, Melchiorre Cervelló   +2 more
exaly  

Structure-based optimization of oxadiazole-based GSK-3 inhibitors

European Journal of Medicinal Chemistry, 2013
Martin Brodrecht, Juan Manuel Dominguez, Fabio Lo Monte   +2 more
exaly  

Cleavage of GSK‐3β by calpain counteracts the inhibitory effect of Ser9 phosphorylation on GSK‐3β activity induced by H2O2

Journal of Neurochemistry, 2013
Yiyuan Xia, Xiaochuan Wang, Jianzhi Wang   +2 more
exaly  

GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS

Frontiers in Molecular Neuroscience, 2011
Ana Martinez, Hagit Eldar-Finkelman, Eldar-Finkelman Hagit   +2 more
exaly  

Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta -catenin and promotes GSK-3beta -dependent phosphorylation of beta -catenin

EMBO Journal, 1998
Shosei Kishida, Hideki Yamamoto
exaly  

Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

Medicinal Research Reviews, 2002
Ana Castro, Ana Martinez
exaly  

Differential Roles of GSK-3β During Myocardial Ischemia and Ischemia/Reperfusion

Circulation Research, 2011
Peiyong Zhai, Sebastiano Sciarretta, Massimo Volpe   +2 more
exaly  

Recent advances in understanding the cellular roles of GSK-3

F1000Research, 2017
James Woodgett, Kevin Cormier
exaly  

Cross talk between PI3K-AKT-GSK-3β and PP2A pathways determines tau hyperphosphorylation

Neurobiology of Aging, 2015
Fei Liu, Jianhua Shi, Jianlan Gu
exaly